Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature

Joshua D Preston,Caroline S Jansen,Siddhartha Kosaraju,Tim Niyogusaba,Tony Z Zhuang,Sally W Iwamoto,Spencer K Hutto,Mary Jo Lechowicz,Pamela B Allen

DOI: https://doi.org/10.2217/cns-2023-0014

2023-12-01

Abstract:Cutaneous T-cell lymphoma (CTCL) is a rare hematologic malignancy that traditionally presents with cutaneous lesions, though metastases are not uncommon in progressive disease. We describe four cases of CTCL with central nervous system (CNS) involvement, detailing the history, pathological characteristics, treatment response, and progression. Median time from initial diagnosis to CNS metastasis was ∼5.4 years (range 3.4-15.5 years) and survival after metastasis was ∼160 days (range 19 days-4.4 years). No patients achieved long-term (>5 years) survival, though some displayed varying degrees of remission following CNS-directed therapy. We conclude that clinicians must be attentive to the development of CNS metastases in patients with CTCL. The growing body of literature on such cases will inform evolving therapeutic guidelines on this rare CTCL complication.